Trials / Sponsors / Central European Cooperative Oncology Group

Central European Cooperative Oncology Group

Academic / Other · 12 registered clinical trials.

Status	Trial	Phase	Started
Terminated	Dacomitinib + Pemetrexed for Patients With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC) Non Small Cell Lung Cancer	Phase 1	2013-07-30
Terminated	A Study Evaluating the Efficacy and Safety of Lapatinib + Vinorelbine in ErbB2 Positive Metastatic Breast Canc Metastatic Breast Cancer	Phase 2	2010-09-01
Completed	2-arm Trial of Paclitaxel Plus Bevacizumab vs. Capecitabine Plus Bevacizumab Metastatic Breast Cancer	Phase 3	2008-04-01
Completed	Safety and Efficacy of Folfox4 + Weekly Cetuximab vs Folfox 4+Biweekly Cetuximab by Metastatic Colorectal Canc Colorectal Cancer	Phase 2	2008-01-01
Completed	Safety and Efficacy of Folfox6 + Cetuximab Versus Folfiri +Cetuximab in Patients With Metastatic Colorectal Ca Metastatic Colorectal Cancer	Phase 2	2005-07-01
Terminated	Phase II Trial of Dose-dense Paclitaxel and Cisplatin as Neo-adjuvant Chemotherapy for Operable Stage II and I Non-Small Cell Lung Cancer	Phase 2	2005-06-01
Completed	Dose Density FU 75 and FU 90 as Adjuvant Therapy for Early Breast Cancer Breast Cancer	Phase 2	2005-04-01
Terminated	Combined Treatment With Capecitabine and Immunotherapy Versus Immunotherapy Alone in Advanced Renal Cell Carci Renal Cell Cancer	Phase 3	2004-03-01
Completed	Open-label Trial of GlivecWith Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumors Gastrointestinal Stromal Tumors	Phase 3	2004-03-01
Terminated	ZOMETA® (Zoledronic Acid) for Prevention of Bone Metastases Prostate Cancer	Phase 3	2003-12-01
Completed	Study Comparing Concomitant Docetaxel + Gemcitabine to Sequential Therapy of Docetaxel Followed by Gemcitabine Breast Cancer	Phase 3	2002-06-01
Completed	An Open, Randomized, Multicentre, Phase II Pilot Study Non-Small Cell Lung Cancer	Phase 2	2001-12-01